How many investments has Noetic made?

Noetic has 36 tracked investments, 2 of which have exited.

What stage does Noetic invest at?

Noetic invests at the Seed, Series A stages.

Where is Noetic located?

Noetic is headquartered in Toronto, CA.

Does Noetic lead rounds?

Yes, Noetic leads investment rounds.

Who does Noetic co-invest with?

Noetic most often shares deals with PsyMed Ventures, JLS, Moore Venture Partners, among 56 tracked co-investors.

Noetic

Venture capital

Toronto · Seed–Series A · 13 people tracked

Also known as GREY HOUSE PARTNERS GP INC.

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Noetic

1,106 people in our graph share verified history with the Noetic team — schools, employers, funds. One of them is your warm intro.

Salim Tejaunlockedknows Sri Teja Mullapudi · together at TIAP - Toronto Innovation Acceleration Partners (overlapped)

knows the team · via TIAP - Toronto Innovation Acceleration Partners

×10knows the team · via Creative Destruction Lab (CDL)

✨ Fox Verdict

Investment thesis

Noetic backs early-stage companies advancing mental, emotional, and physiological health. Its diversified, multi-modal strategy covers novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables, and other evidence-backed solutions, with a global outlook. The firm emphasizes CNS-targeted therapeutics and sustainable solutions that address the root causes of illness, prioritizing early intervention and prevention. Noetic seeks teams with the skills, expertise, management experience, and governance to build world-class companies, aiming to create a better, more accessible mental health landscape for current and future generations.

Invests inBiotech Digital Health Healthtech Longevity Medical Devices Mental Health Wellness & Fitness Canada Global Grand Cayman Toronto Toronto, Ontario United Kingdom United States

Source: firm website, verified Sep 27, 2026.

Stage

Seed–Series A

Toronto, Ontario, CA

Leads rounds

Leads

Instruments

Equity

Founded

2020

Private fund assets

$148.1M

VC funds

Tracked investments

IPOs

Team · 13 people

from the firm's website & public directories

David Lloyd· General Partner

Mark Anthony· General Partner

Michael Franks· General Partner

Sa'ad Shah· Managing Partner· Toronto, Ontario, Canadain

Spent nine years at RBC Capital Markets in real estate banking, corporate credit, and derivatives, and nine years at DGAM (acquired by Carlyle) as Head of Marketing and Client Services. Holds a B.A. in Economics and Political Science from Columbia University.

s•••@noeticfund.comreveal

Warren Wright· Managing Partner· Toronto, Ontario, Canadain

Former Managing Director and Head of Hedge Fund Investments at Northwater Capital Management and Chief Investment Officer at DGAM (acquired by Carlyle). Was a Partner at The Carlyle Group and CIO of its Liquid Markets Group.

w•••@noeticfund.comreveal

Sri Teja Mullapudi· Principal, Fund Investments, Scientific Lead· Canadain

Helped raise and deploy over $60M in the psychedelic and neuroscience sectors and has life sciences investment analysis experience from TIAP. Holds a Ph.D. in Biology from the Max Planck Society and M.Tech/B.Tech in Biotechnology from IIT Madras.

Yee Tan· Principal, Finance, Operations· Toronto, Ontario, Canadain

Spent 25+ years at RBC across retail banking, finance, corporate credit, and FX sales, with extensive experience structuring and executing cross-border transactions for corporate clients. Holds a B.Comm in Finance from Dalhousie University and is a CFA.

Jeffrey Becker· Venture Partner· Santa Barbara, California, United Statesin

CSO and co-founder of Bexson Biomedical, board-certified in Psychiatry and Integrative & Holistic Medicine, and a ketamine-assisted psychotherapy trainer. UCLA medical graduate with a Biology degree from UC Berkeley.

Craig Hippern· Advisor· Toronto, Ontario, Canadain

Has 25+ years in the onshore and offshore investment industry, including CFO roles and 8.5 years at Northwater Capital Management in finance, risk management, and hedge fund due diligence. A CPA in both Canada and the U.S.

Marine Mallinson· Venture Advisor· London, England, United Kingdomin

A tech entrepreneur with two exits and a board member and investor in mental health companies. Former co-founder CEO of an AI-powered social network for cancer patients and ex-investment banker in Tokyo; holds degrees from Sciences Po Paris and INALCO Paris.

Richard Cheung· General Counsel

Has 15+ years advising on intellectual property and regulated health products at firms including Fasken and Bereskin & Parr. A licensed pharmacist and registered patent and trademark agent, he holds an LL.B. from Western and a Ph.D. and B.Sc.Phm. from the University of Toronto.

Victor Mifsud· Head of Real World Evidence· Toronto, Ontario, Canadain

Has 10+ years in the psychedelic and health optimization space and founded the Vision Optimization Summit. Completed a feature-length documentary and studied New Media & Film at Ryerson University.

David Rabin

What they invest in

from 23 of 36 portfolio companies

Biotech ×17Digital Health ×14Healthtech ×13Mental Health ×11Medical Devices ×6Wellness & Fitness ×6Deep Tech ×5AI & Machine Learning ×3

HQs:United States×8Canada×3United Kingdom×1

Who they back

founder profiles across 14 portfolio companies

64%

solo founders

9 of 14 mapped founding teams

38%

repeat founders

of 16 founders with career history

Founding team size:solo founder×92 founders×44+ founders×1

What their founders studiedfrom 13 founders with field-of-study data

Life Sciences ×5Finance & Accounting ×3Law ×3Social Sciences ×3Business & Management ×2Chemistry ×2Humanities ×2Medicine ×2

Where their founders worked beforefrom 16 founders with career history

Columbia University in the City of New York ×3Gilgamesh Pharma ×2

Investments · 36 tracked

founders shown can be your intro path

By year:2023 · 1 2022 · 1 2020 · 13 dated

Compass Pathwayscompasspathways.com in 𝕏NASDAQ: CMPS

Compass Pathways develops novel treatments for mental health conditions, with a focus on psychedelic-assisted therapies supported by rigorous clinical research.

BiotechDigital HealthHealthtechMedical DevicesMental Health

Kabir Nath(CEO)

Co-investorsAble Partners Aisling Capital Catalio Capital Management, LP OMX Ventures Vivo Capital Jam Fund

Helus Pharmahelus.com in 𝕏NASDAQ: HELP

Helus Pharma is a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions such as depression, anxiety, schizophrenia, and bipolar disorder.

BiotechDigital HealthHealthtechMental HealthToronto, CA

Eric So(Co-Founder, Executive Chairman)in John Kanakis(Co-Founder)in Paul Glavine(Co-Founder and Chief Growth Officer)inGabriel Fahel(Executive Officer)Douglas Drysdale(Executive Officer)Jacqueline Poriadjian(Executive Officer)

Co-investorsInnovating Capital JLS O2h Ventures

Apolloapolloneuro.com in 𝕏Feb 2023

Apollo Neuro makes a wearable device that delivers gentle vibrations ("SmartVibes") intended to balance the autonomic nervous system, aiming to reduce stress, improve sleep, focus, and recovery.

Digital HealthHardwareHealthtechWellness & FitnessPittsburgh, US

Kathryn Fantauzzi(Co-founder and CEO)inDr. David Rabin MD, PhD(Co-founder; neuroscientist and board-certified psychiatrist)

Board seat Sa'ad Shah· per SEC Form D

Co-investorsID8 Investments Portfolia B Capital Bain Capital Ventures Nexus Venture Partners SeaX Ventures +2 more

Beckley Psytechbeckleypsytech.com

AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.

BiotechMedical DevicesMental Health

Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao

Co-investorsFJ Labs Iter Investments Leafy Tunnel Palo Santo VC Redbus Ventures What If Ventures +1 more

CaaMTechcaam.tech in 𝕏

CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening.

BiotechDeep TechMental Health

Andrew Chadeayne(Founder & CEO)inDavis Wuolle(Chief Technology Officer & Chief Marketing Officer)in

Co-investorsKortschak Investments L.P.

DAMONA Pharmaceuticalsdamonapharma.com in

Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Co-investorsAngelini Ventures Lumira Ventures Toronto Innovation Acceleration Partners

Delixdelixtherapeutics.com in

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

Co-investorsArtis Ventures Casa Verde Capital Dolby Family Ventures OMX Ventures Palo Santo VC PsyMed Ventures +6 more

Diamond Therapeuticsdiamondthera.com in

Diamond Therapeutics is a preclinical biotechnology company developing drug treatments for psychiatric and neurological disorders, with a focus on the pharmacology and therapeutic use of psychedelic compounds.

BiotechHealthtechMental HealthToronto, CA

Judy Blumstock(Chief Executive Officer, Founder, Director)inMichael B. McDonnell(Chief Medical Officer)Grant McCutcheon(Chief Financial Officer)in

Co-investorsJLS Palo Santo VC New Enterprise Associates (NEA)Nextech Invest RA Capital

Eleusiseleusisltd.comFeb 2022

Focused on serotonin 2A receptor agonists (psychedelics) by managing psychoactivity.

BiotechNew York, US

Shlomi Raz(Director)Robert M. Hershberg(Director)David Socks(Director)Joanna Grace Natasegara(Director)Mary Frances Vernon(Director)John Bryan Clifton(Director)

Gilgamesh Pharmaceuticalsgilgameshpharmaceutical.com in 𝕏

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

Jonathan Sporn(Founder)in Andrew Kruegel(Founder)in Dalibor Sames(Founder)in JONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Jonathan Sporn, M.D.(President and Chief Executive Officer)in

Co-investorsAera VC Frontera Technology Ventures Frontier Path VC James Beshara Fund JLS Magnetic Ventures +10 more

Merlyn Mindmerlyn.org in 𝕏

Merlyn builds AI-based solutions designed for education, aimed at schools and classrooms.

AI & Machine LearningEdTech

Co-investorsWestern Technology Investment Learn Capital

Mind Medicine (MindMed)mindmed.co in 𝕏

MindMed is a biotech company developing psychedelic-based therapeutics, including a proprietary orally disintegrating LSD tablet (DT120) and an R-enantiomer of MDMA (DT402), to treat brain health disorders such as generalized anxiety disorder, major depressive disorder, PTSD, and autism spectrum disorder.

BiotechDigital HealthMental HealthNew York, US

Stephen Hurst(Executive Officer, Director, Promoter)inScott Freeman(Executive Officer)JR Rahn(Director)STEPHEN HURST(Executive Officer, Director)inJAMON ALEXANDER RAHN(Executive Officer, Director)Carrie Liao(Executive Officer)in

Co-investorsBT Growth Capital Daft Capital K2 HealthVentures

MindMeddefiniumtx.com in 𝕏

Definium Therapeutics is a biotech company developing psychedelic-based treatments for brain health disorders, including formulations of LSD and MDMA enantiomers targeting depression, anxiety, PTSD, and autism spectrum disorder.

BiotechDigital HealthMental Health

Numinusnuminuswellness.com

Operating company addressing mental health and wellness.

People Sciencepeoplescience.health in

People Science runs real-world clinical research for the health and wellness industry, offering a decentralized clinical trial platform (Chloe Clinical) and a real-world data collection tool (Chloe LiveLab) alongside clinical research services.

Digital HealthHealthtechWellness & Fitness

Noah Craft(Founder)in

Co-investorsAcre Venture Partners FTW Ventures Lifeforce Capital Bluestein Ventures SUPPLY CHANGE CAPITAL

Psychcentralpsychcentral.com

Psych Central is a digital publisher providing informational content on mental health, wellness, and medical topics developed in collaboration with licensed medical professionals.

Digital HealthHealthtechMedia & EntertainmentMental HealthWellness & Fitness

Psygenpsygen.ca in 𝕏

Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use.

BiotechDeep TechHealthtechMedical DevicesMental Health

Danny Motyka(Co-Founder & CEO)inPeter van der Heyden(Co-Founder & Director)in

Co-investorsIter Investments Eight Capital

Sana Healthsana.io in

Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.

Digital HealthHealthtechMedical DevicesMental HealthLafayette, US

Richard Hanbury(Founder)in

Co-investorsAsia Africa Investment & Consulting (AAIC)Checkmate Capital Group LLC Click Ventures Esplanade Ventures Flucas Ventures Harmonix Fund +6 more

Shulginresearchshulginresearch.net

A psychedelics research organization that discovers new psychoactive substances and develops compounds and delivery systems for therapeutic use, continuing the work of Dr.

BiotechDeep TechDigital Health

Tactogentactogen.com in 𝕏

Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.

BiotechDeep TechHealthtech

Matthew Baggott(CEO)in

Co-investorsLeafy Tunnel PsyMed Ventures 10X Capital Palo Santo VC Wefunder

Terranterranbiosciences.com

Terran Biosciences is a biotech platform company developing therapeutics and technologies for neurological and psychiatric diseases, including late-stage drug candidates for schizophrenia, psychedelic and empathogen compounds, and an AI-based neuromelanin MRI analysis platform.

AI & Machine LearningBiotechDigital Health

Sam Clark(Chief Executive Officer)Dustin Tetzl(Chief Business Officer)

Co-investorsPsyMed Ventures Red Beard Ventures

Vessel Healthvesselhealth.com inDec 2020

Vessel Health offers at-home urine testing and health monitoring solutions designed to help users track and improve their wellness.

Digital HealthHealthtechWellness & FitnessSan Diego, US

Jon Carder(Executive Officer, Director)in

BoardJared Stein(Director)

Co-investorsCove Fund Interlock Capital Moore Venture Partners City Light

Wakewake.net in 𝕏

Wake offers medicinal and psychedelic fungi therapy combined with genomics-based integration aimed at supporting human health and personal transformation.

BiotechHealthtechWellness & Fitness

Nick Murray(Founder)in

Woven Sciencewoven.science in 𝕏

Woven Science backs, incubates, and builds companies in the psychedelic and wellness space, operating across drug development, health technology, and plant-medicine product development and distribution.

BiotechMental HealthWellness & Fitness

Nick von Christierson(CEO & Co-Founder)inGiles Hayward(President & Co-Founder)in Riwa Harfoush(Chief Strategy Officer)inLouis Sagar(Chief Experience Officer)inHelen Sartory(Chief Financial Officer)in

Co-investorsBattery Ventures Falfurrias IVP (Institutional Venture Partners)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AccesswireAlexander Shulgin Research InstituteApaApollo NeuroscienceBexson BiomedicalCybinPsyBio TherapeuticsPsybiolifePsychedelic Drugs KPMGstate capital gainsTerran BiosciencesVessel

Exits · 2

2 IPOs

Compass PathwaysNASDAQ: CMPSHelus PharmaNASDAQ: HELP

Frequently asked questions

How many investments has Noetic made?: Noetic has 36 tracked investments, 2 of which have exited.
What stage does Noetic invest at?: Noetic invests at the Seed, Series A stages.
What sectors does Noetic focus on?: Noetic focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health, Wellness & Fitness.
Where is Noetic located?: Noetic is headquartered in Toronto, CA.
Does Noetic lead rounds?: Yes, Noetic leads investment rounds.
Who does Noetic co-invest with?: Noetic most often shares deals with PsyMed Ventures, JLS, Moore Venture Partners, among 56 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Sa'ad Shah, Investing $150M to Fix The Mental Health Crisis With Noetic Capital | Brick By Brick 014

Ollie Allen Fox · Sa'ad Shah

#opnaskaninvestor - Sa'ad Shah, Managing Partner, Noetic Fund

Open People Network · Sa'ad Shah

Images

Similar investors

JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.

$100K – $20M

LongeVC

LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.

PsyMed Ventures

PsyMed Ventures is an early-stage venture firm investing in neuroscience and frontier technologies aimed at improving brain and mental health.

IKJ Capital

IKJ Capital is a venture capital firm investing in early-stage healthcare technology companies, with a focus on mental health, chronic conditions, and longevity. It operates across the Americas from Palo Alto, New York, and São Paulo.

P5 Health Ventures

P5 Health Ventures (P5HV) is an investment firm with a primary focus on healthcare technologies, backing companies that use AI and technology to lower the cost of care while improving quality and accessibility.